@article {904,
	title = {A Search for Mosquito Larvicidal Compounds by Blocking the Sterol Carrying Protein, AeSCP-2, through Computational Screening and Docking Strategies},
	journal = {Pharmacognosy Research},
	volume = {3},
	year = {2011},
	month = {November,2011},
	pages = {273},
	type = {letter to the editor},
	chapter = {273},
	abstract = {<p class="rtejustify">Sir, We would like to add a note that in our recent publication on {\textquotedblleft}A search for mosquito larvicidal compounds by blocking the sterol carrying protein, AeSCP-2, through computational screening and docking strategies{\textquotedblright}[1] and reported the results based on in silico docking experiments that α-mangostin as a best inhibitor; however, Larson et al. 2010[2] performed assay-based screening and assessed the toxicity and dosage levels of -mangostin. Unfortunately, we missed citing this article which would be important to explain our results and this is not intentional. We greatly acknowledge Dr. Q. Lan for intimating us the same.</p>
},
	doi = {10.4103/0974-8490.89749},
	author = {R. Barani Kumar}
}
